Newsroom

Newsroom

EBV-Positive Primary Large B-Cell Lymphoma: The Role of Immunohistochemistry and XPO1 in the Diagnosis of Mediastinal Lymphomas

Press Release
Read More

Being Comprehensive in Hematologic Malignancies

Blog
Read More

A large study of PIK3CA mutations in the community setting identifies varying degree of mutation positivity rates across age groups in advanced HR+, HER2- breast cancer patients using and FDA TR-PCR cleared test3

Literature
Read More

An Integrated Multiplexing Approach Identifies IDO1 as a Biomarker for Recurrence of Rare Ovarian Granulosa Cell Tumors

Literature
Read More

NeoGenomics To Participate In Fireside Chat At Stephens 21st Annual Investment Conference

Press Release
Read More

NeoGenomics Reports 51% Revenue Growth to $105 Million in the Third Quarter

Press Release
Read More

An Integrated Multiplexing Approach for the Immunoprofiling of the Tumor Microenvironment of Ovarian Granulosa Cell Tumors

Literature
Read More

The ever-changing world of gene fusions in cancer: a secondary gene fusion and progression

Literature
Read More

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients